NAOMI AMUDALA: Open Payments
NPI 1154655348 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$38,342 in 55 payments from 6 companies in 2025. Trend: 2023 $12,258 · 2024 $27,810 · 2025 $38,342
Speaker / faculty: $19,641Consulting: $13,663Travel & lodging: $3,541Food & beverage: $1,443Education: $55
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 24 | $15,066 |
| Janssen Biotech, Inc. | 16 | $11,247 |
| Novartis Pharmaceuticals Corporation | 7 | $4,971 |
| Janssen Scientific Affairs, LLC | 5 | $3,998 |
| Eli Lilly and Company | 2 | $2,200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $860 |
Products named: TREMFYA, TAVNEOS, TALTZ, UPLIZNA.
Industry payments across MA — which companies pay providers there.
